ConvaTec Group (CTEC) Competitors GBX 242.16 -0.64 (-0.26%) As of 08/22/2025 12:38 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesBuy This Stock CTEC vs. AMS, TSTL, BVC, SPEC, AKR, CNSL, ODX, SN, IDHC, and HIKShould you be buying ConvaTec Group stock or one of its competitors? The main competitors of ConvaTec Group include Advanced Medical Solutions Group (AMS), Tristel (TSTL), BATM Advanced Communications (BVC), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), Smith & Nephew (SN), Integrated Diagnostics (IDHC), and Hikma Pharmaceuticals (HIK). These companies are all part of the "medical" sector. ConvaTec Group vs. Its Competitors Advanced Medical Solutions Group Tristel BATM Advanced Communications INSPECS Group Akers Biosciences Cambridge Nutritional Sciences Omega Diagnostics Group Smith & Nephew Integrated Diagnostics Hikma Pharmaceuticals Advanced Medical Solutions Group (LON:AMS) and ConvaTec Group (LON:CTEC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations. Which has higher valuation and earnings, AMS or CTEC? ConvaTec Group has higher revenue and earnings than Advanced Medical Solutions Group. Advanced Medical Solutions Group is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdvanced Medical Solutions Group£132.18M3.40£11.22M£5.1640.31ConvaTec Group£2.71B2.28£188.35M£5.9440.78 Is AMS or CTEC more profitable? Advanced Medical Solutions Group has a net margin of 8.49% compared to ConvaTec Group's net margin of 6.96%. ConvaTec Group's return on equity of 9.15% beat Advanced Medical Solutions Group's return on equity.Company Net Margins Return on Equity Return on Assets Advanced Medical Solutions Group8.49% 4.57% 2.35% ConvaTec Group 6.96%9.15%5.01% Does the media favor AMS or CTEC? In the previous week, ConvaTec Group had 15 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 16 mentions for ConvaTec Group and 1 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 1.43 beat ConvaTec Group's score of 0.19 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Advanced Medical Solutions Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ConvaTec Group 1 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Do analysts prefer AMS or CTEC? Advanced Medical Solutions Group currently has a consensus price target of GBX 287.50, suggesting a potential upside of 38.22%. ConvaTec Group has a consensus price target of GBX 309.40, suggesting a potential upside of 27.77%. Given Advanced Medical Solutions Group's higher probable upside, research analysts plainly believe Advanced Medical Solutions Group is more favorable than ConvaTec Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Medical Solutions Group 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00ConvaTec Group 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of AMS or CTEC? 58.2% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 69.1% of ConvaTec Group shares are owned by institutional investors. 3.1% of Advanced Medical Solutions Group shares are owned by company insiders. Comparatively, 19.7% of ConvaTec Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more risk and volatility, AMS or CTEC? Advanced Medical Solutions Group has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500. Comparatively, ConvaTec Group has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500. Is AMS or CTEC a better dividend stock? Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 1.0%. ConvaTec Group pays an annual dividend of GBX 5 per share and has a dividend yield of 2.1%. Advanced Medical Solutions Group pays out 38.8% of its earnings in the form of a dividend. ConvaTec Group pays out 84.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. SummaryConvaTec Group beats Advanced Medical Solutions Group on 11 of the 17 factors compared between the two stocks. Get ConvaTec Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CTEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTEC vs. The Competition Export to ExcelMetricConvaTec GroupMedical Instruments & Supplies IndustryMedical SectorLON ExchangeMarket Cap£6.16B£3.15B£5.77B£3.22BDividend Yield1.27%1.99%4.40%5.04%P/E Ratio40.7818.0330.33164.70Price / Sales2.28300.88469.88310,111.42Price / Cash17.01146.5425.7827.93Price / Book3.032.319.495.91Net Income£188.35M£99.80M£3.27B£5.89B7 Day Performance5.01%0.40%2.53%49.44%1 Month Performance0.64%-1.76%4.05%58.03%1 Year Performance2.87%116.01%30.79%141.20% ConvaTec Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTECConvaTec Group4.0206 of 5 starsGBX 242.16-0.3%GBX 309.40+27.8%+2.9%£6.16B£2.71B40.7810,000AMSAdvanced Medical Solutions Group2.4488 of 5 starsGBX 204.50+0.2%GBX 287.50+40.6%-17.9%£441.57M£132.18M39.6310Positive NewsTSTLTristel0.527 of 5 starsGBX 355.50-1.3%GBX 400+12.5%-23.2%£169.82M£42.24M26.02208BVCBATM Advanced CommunicationsN/AGBX 15.49+5.0%N/A-22.2%£82.25M£130.32M-359.56980Gap DownHigh Trading VolumeSPECINSPECS GroupN/AGBX 44.15-7.1%N/A-17.0%£44.89M£195.14M-10.931,673Gap DownAKRAkers BiosciencesN/AN/AN/AN/A£21.64M£2.32M-0.44120CNSLCambridge Nutritional SciencesN/AGBX 3.10-11.4%N/A-14.4%£7.38M£9.77M-362.103,200Earnings ReportGap UpHigh Trading VolumeODXOmega Diagnostics GroupN/AN/AN/AN/A£5.23M£7.55M-220.0091Gap DownSNSmith & Nephew2.2861 of 5 starsGBX 1,348+0.2%GBX 1,379.33+2.3%+18.1%£14.78B£7.08B48.5318,452High Trading VolumeIDHCIntegrated DiagnosticsN/AGBX 0.42+1.2%N/AN/A£12.36B£23.29T15.616,692HIKHikma Pharmaceuticals4.2145 of 5 starsGBX 1,809.13+0.4%GBX 2,627.50+45.2%-8.8%£5.02B£3.74B17.759,100Insider Trade Related Companies and Tools Related Companies Advanced Medical Solutions Group Competitors Tristel Competitors BATM Advanced Communications Competitors INSPECS Group Competitors Akers Biosciences Competitors Cambridge Nutritional Sciences Competitors Omega Diagnostics Group Competitors Smith & Nephew Competitors Integrated Diagnostics Competitors Hikma Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CTEC) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ConvaTec Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share ConvaTec Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.